Impaired microRNA processing enhances cellular transformation and tumorigenesis

Nature Genetics

Volumn 39, Issue 5, 2007, Pages 673-677

  Kumar, Madhu S ^a   Lu, Jun ^b,c   Mercer, Kim L ^a   Golub, Todd R ^b,c,d   Jacks, Tyler ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; GENE DELETION; GENE LOSS; GENE REPRESSION; HUMAN; HUMAN CELL; LUNG CARCINOGENESIS; LUNG CARCINOMA; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE K RAS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA PROCESSING; RNA SEQUENCE; RNA SYNTHESIS;

ANIMALS; BROMODEOXYURIDINE; CARCINOGENICITY TESTS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOBLOTTING; LUCIFERASES; MICE; MICRORNAS; NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEASE III;

ANIMALIA;

EID: 34247593034     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng2003     Document Type: Article

References (29)

1. Bartel, D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
2. Gregory, R.I. & Shiekhattar, R. MicroRNA biogenesis and cancer. Cancer Res. 65, 3509-3512 (2005).
3. Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834-838 (2005).
4. Wislez, M. et al. High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. Cancer Res. 66, 4198-4207 (2006).
5. Johnson, L. et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410, 1111-1116 (2001).
6. Harfe, B.D., McManus, M.T., Mansfield, J.H., Hornstein, E. & Tabin, C.J. The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc. Natl. Acad. Sci. USA 102, 10898-10903 (2005).
7. Kanellopoulou, C. et al. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev. 19, 489-501 (2005).
8. Murchison, E.P., Partridge, J.F., Tam, O.H., Cheloufi, S. & Hannon, G.J. Characterization of Dicer-deficient murine embryonic stem cells. Proc. Natl. Acad. Sci. USA 102, 12135-12140 (2005).
9. Ventura, A. et al. Cre-lox-regulated conditional RNA interference fromtransgenes. Proc. Natl. Acad. Sci. USA 101, 10380-10385 (2004).
10. Tuveson, D.A. et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 5, 375-387 (2004).
11. Adhikary, S. & Eilers, M. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol. 6, 635-645 (2005).
12. John, B. et al. Human MicroRNA targets. PLoS Biol. 2, e363 (2004).
13. Johnson, S.M. et al. RAS is regulated by the let-7 microRNA family. Cell 120, 635-647 (2005).
14. Jackson, E.L. et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15, 3243-3248 (2001).
15. Karube, Y. et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. 96, 111-115 (2005).
16. Hayashita, Y. et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 65, 9628-9632 (2005).
17. He, L. et al. A microRNA polycistron as a potential human oncogene. Nature 435, 828-833 (2005).
18. O'Donnell, K.A., Wentzel, E.A., Zeller, K.I., Dang, C.V. & Mendell, J.T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839-843 (2005).
19. Ota, A. et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 64, 3087-3095 (2004).
20. Volinia, S. et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103, 2257-2261 (2006).
21. Thomson, J.M. et al. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 20, 2202-2207 (2006).
22. Sage, J. et al. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 14, 3037-3050 (2000).
23. Brummelkamp, T.R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553 (2002).
24. Sweet-Cordero, A. et al. An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. Nat. Genet. 37, 48-55 (2005).
25. Martens, J.H. et al. The profile of repeat-associated histone lysine methylation states in the mouse epigenome. EMBO J. 24, 800-812 (2005).
26. Hutvagner, G., Simard, M.J., Mello, C.C. & Zamore, P.D. Sequence-specific inhibition of small RNA function. PLoS Biol. 2, E98 (2004).
27. Meister, G., Landthaler, M., Dorsett, Y. & Tuschl, T. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10, 544-550 (2004).
28. Doench, J.G., Petersen, C.P. & Sharp, P.A. siRNAs can function as miRNAs. Genes Dev. 17, 438-442 (2003).
29. Jackson, E.L. et al. The differential effects of mutant p53 alleles on advanced murine lung cancer. Cancer Res. 65, 10280-10288 (2005).